Mike Glover
Mike is a Senior Pharmaceutical Executive with a diverse background across multiple geographies, functions and therapeutic areas. Mike has Global commercial leadership spanning Oncology, Cardiovascular, Diabetes and Virology from asset development to in market delivery along with extensive experience in developing and executing cutting edge access, policy and pricing strategies executing a fully integrated market access program. Mike has held roles in AZ, BMS and Pfizer and is currently Vice President Global Access for GSK Oncology.
Mike is a Senior Pharmaceutical Executive with a diverse background across multiple geographies, functions and therapeutic areas. Mike has Global commercial leadership spanning Oncology, Cardiovascular, Diabetes and Virology from asset development to in market delivery along with extensive experience in developing and executing cutting edge access, policy and pricing strategies executing a fully integrated market access program. Mike has held roles in AZ, BMS and Pfizer and is currently Vice President Global Access for GSK Oncology.
See more
Articles: Mike Glover
Putting People Ahead of the Maths: Addressing the Limitations of Today’s Approach to HTA
Opinion / Mike Glover, Vice President Global Head of Access and Pricing Strategy Oncology at GSK outlines that while new mathematical approaches to health technology assessment (HTA) have been hugely beneficial, a broader approach that includes the insights of individual people is necessary to truly drive forward better health outcomes. The words “people” and “maths” have…
Latest Report
